Asymmetric membrane capsule for osmotic delivery of flurbiprofen

Acta Pharmaceutica

Volumn 57, Issue 3, 2007, Pages 343-350

  Choudhury, Pratim K ^a   Ranawat, Mahendra S ^b   Pillai, Mousumi K ^c   Chauhan, Chetan S ^b  

^a FIJI SCHOOL OF MEDICINE   (Fiji)

^b BN College of Pharmacy   (India)

^c M L SUKHADIA UNIVERSITY   (India)

Author keywords

Asymmetric membrane; Cellulose acetate; Flurbiprofen; Osmogent; Osmotic delivery

Indexed keywords

CELLULOSE ACETATE; DODECYL SULFATE SODIUM; DYE; FLURBIPROFEN; MANNITOL; SODIUM CHLORIDE; SOLUBILIZER;

ARTICLE; CORRELATION ANALYSIS; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; ENCAPSULATION; IN VITRO STUDY; OSMOSIS; OSMOTIC PRESSURE; POROSITY; SCANNING ELECTRON MICROSCOPY;

EID: 34548774570     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-007-0027-3     Document Type: Article

References (14)

1. F. Theeuwes, Elementary osmotic pump, J. Pharm. Sci. 64 (1975) 1987-1991.
2. G. Santus and W. R. Baker, Osmotic drug delivery: A review of patent literature, J. Control. Rel. 35 (1995) 1-21; DOI: 10.1016/0168-3659(95)00013-X.
3. R. K. Verma, D. M. Krishna and S. Garg, Formulation aspects in the development of osmotically controlled oral drug delivery systems, J. Control. Rel. 79 (2002) 7-27; DOI: 10.1016/S0168-3659 (01)00550-8.
4. A. G. Thombre, J. R. Cardinal, A. R. DeNoto and D. C. Gibbs, Asymmetric membrane capsule for osmotic drug delivery II. In vitro and in vivo drug release performance, J. Control. Rel. 57 (1999) 65-73; DOI: 10.1016/S0168-3659(98)00101-1.
5. A. G. Thombre, J. R. Cardinal, A. R. DeNoto, S. M. Herbig and K. L. Smith, Asymmetric membrane capsule for osmotic drug delivery I. Development of manufacturing process, J. Control. Rel. 57 (1999) 55-64; DOI: 10.1016/S0168-3659(98)00100-X.
6. S. M. Herbig, J. R. Cardinal, R. W. Korsmeyer and K. L. Smith, Asymmetric membrane tablet coatings for osmotic drug delivery, J. Control. Rel. 35 (1995) 127-136; DOI: 10.1016/0168-3659 (95)00028-7.
7. Y.-K. Lin and H. Ho, Investigation on the drug releasing mechanism from an asymmetric membrane coated capsule with an in situ formed delivery orifice, J. Control. Rel. 89 (2003) 57-69; DOI: 10.1016/S0168-3659(03) 00091-9.
8. G. M. Zentner, G. S. Rork and K. J. Himmelsteine, Osmotic flow through controlled porosity films: An approach to deliver water-soluble compounds, J. Control. Rel. 2 (1985) 217-229.
9. S. N. Makhija and P. R. Vavia, Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine I. Cellulose acetate as semipermeable membrane, J. Control. Rel. 89 (2003) 5-18; DOI: 10.1016/S0168-3659(02)00482-0.
10. F. Theeuwes, D. R. Swanson, G. Guittard, A. Ayer and S. Khanna, Osmotic delivery systems for the beta-adrenoceptor anatagonists metoprolol and oxprenolol: design and evaluation for once-daily administration, Br. Clin. Pharmacol. 19 (1985) 69S-76S.
11. C. S. Chauhan and P. K. Choudhury, Controlled porosity osmotic pump for the delivery of flurbiprofen, Curr. Drug Deliv. 3 (2006) 193-198.
12. st ed., Pharmaceutical Press, London, 1996, p. 999-1000.
13. United States Pharmacopoeia 24, National Formulary 19, USP Convention, Rockville 2001, pp. 2051.
14. st ed., Marcel Dekker, New Jersey 2000, pp. 751-785.